Miguel Barbosa
Keine laufenden Positionen mehr
Profil
Miguel Barbosa served as the Chief Scientific Officer at Mirna Therapeutics, Inc. from 2015 to 2016.
Prior to that, he was the Chief Scientific Officer-Microbiome Program at Assembly Biosciences, Inc. He also worked as the Vice President-Immunology Research at Janssen Research & Development LLC.
Barbosa holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Davis.
Ehemalige bekannte Positionen von Miguel Barbosa
| Unternehmen | Position | Ende |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.10.2017 |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Technik-/Wissenschafts-/F&E-Leiter | 29.06.2016 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Ausbildung von Miguel Barbosa
| University of California, Davis | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
